How we underwrite risk
The Cost of Waiting for Certainty
In emerging markets, skepticism is essential—but it becomes costly when it replaces analysis of the underlying business, technology, and direction of change.
Uncertainty is not the same as weakness
The earliest evidence around a new market is rarely complete. The category may be unfamiliar, its path to adoption may be unclear, and the public narrative may be shaped more by anxiety than by operating facts.
Those conditions deserve serious scrutiny. But they do not, on their own, establish that a company lacks durable economics, that a technology lacks a credible path, or that a market will not mature.
Separate the business from the category
A difficult category can still contain a strong business. Conversely, an exciting category can conceal weak fundamentals. The work is to assess the company on its own merits: customer demand, economics, competitive position, execution, and the specific risks that could impair the outcome.
When a broad social or regulatory narrative becomes a substitute for that analysis, it can turn an understandable concern into an automatic rejection.
Separate excess from direction
Emerging industries often attract excess. Expectations can run ahead of reality, valuations can overshoot, and some participants will fail. None of that should be ignored.
Yet the presence of speculation does not prove that the underlying direction is meaningless. A sound investment process distinguishes temporary noise from the structural shifts that can reshape how value is created over time.
Skepticism should sharpen the work
The objective is neither blind optimism nor reflexive doubt. It is to ask whether an objection identifies a true fault in the investment case, or merely describes the discomfort of evaluating something before it has become familiar.
That discipline does not mean pursuing every unconventional opportunity. It means refusing to let the absence of complete comfort replace independent judgment.